PGNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PGNX Shares Outstanding History and PGNX YTD Return |
PGNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PGNX Shares Outstanding History and PGNX YTD Return |
PGNX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+8.29% CAGR Mouse over chart for data details
|
PGNX Stock Price Chart |
About Progenics Pharmaceuticals, Inc. |
Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. Co.'s product candidates include: AZEDRA® (iobenguane I 131), which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and 1095, which is a prostate-specific membrane antigen-targeted iodine-131 labeled small molecule that is designed to deliver a dose of beta radiation directly to prostate cancer cells with minimal impact on the surrounding healthy tissues. We show 44 historical shares outstanding datapoints in our PGNX shares outstanding history coverage, used to compute PGNX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PGNX market cap history over the course of time is important for investors interested in comparing PGNX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PGNX versus a peer is one thing; comparing PGNX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PGNX can fluctuate over the course of history. With this page we aim to empower investors researching PGNX by allowing them to research the PGNX market cap history. |
PGNX Current Stock Quote |
Free PGNX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
PGNX Share Performance |
Market Cap Peers |
Progenics Pharmaceuticals (PGNX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
PGNY Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.